A randomized, controlled study of peginterferon lambda-1a/ribavirin +/- daclatasvir for hepatitis C virus genotype 2 or 3

Graham R. Foster, Kazuaki Chayama, Wan-Long Chuang, Hugo Fainboim, Martti Farkkila, Adrian Gadano, Giovanni B. Gaeta, Christophe Hezode, Yukiko Inada, Jeong Heo, Hiromitsu Kumada, Sheng-Nan Lu, Patrick Marcellin, Christophe Moreno, Stuart K. Roberts, Simone I. Strasser, Alexander J. Thompson, Joji Toyota, Seung Woon Paik, John M. VierlingAnna L. Zignego, David Cohen, Fiona McPhee, Megan Wind-Rotolo, Subasree Srinivasan, Matthew Hruska, Heather Myler, Simon D. Portsmouth

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

Alkuperäiskielienglanti
Artikkeli1365
LehtiSpringerPlus
Vuosikerta5
Sivumäärä12
ISSN2193-1801
DOI - pysyväislinkit
TilaJulkaistu - 19 elokuuta 2016
OKM-julkaisutyyppiA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

  • 3121 Sisätaudit

Lainaa tätä

Foster, Graham R. ; Chayama, Kazuaki ; Chuang, Wan-Long ; Fainboim, Hugo ; Farkkila, Martti ; Gadano, Adrian ; Gaeta, Giovanni B. ; Hezode, Christophe ; Inada, Yukiko ; Heo, Jeong ; Kumada, Hiromitsu ; Lu, Sheng-Nan ; Marcellin, Patrick ; Moreno, Christophe ; Roberts, Stuart K. ; Strasser, Simone I. ; Thompson, Alexander J. ; Toyota, Joji ; Paik, Seung Woon ; Vierling, John M. ; Zignego, Anna L. ; Cohen, David ; McPhee, Fiona ; Wind-Rotolo, Megan ; Srinivasan, Subasree ; Hruska, Matthew ; Myler, Heather ; Portsmouth, Simon D. / A randomized, controlled study of peginterferon lambda-1a/ribavirin +/- daclatasvir for hepatitis C virus genotype 2 or 3. Julkaisussa: SpringerPlus. 2016 ; Vuosikerta 5.
@article{9f50945e77054ed9a1807c04f697067b,
title = "A randomized, controlled study of peginterferon lambda-1a/ribavirin +/- daclatasvir for hepatitis C virus genotype 2 or 3",
keywords = "Hepatitis C virus, Genotype 2, Genotype 3, Peginterferon lambda-1a, Peginterferon alfa-2a, PLUS SOFOSBUVIR, HCV GENOTYPE-2, RIBAVIRIN, THERAPY, INFECTION, CIRRHOSIS, 3121 Internal medicine",
author = "Foster, {Graham R.} and Kazuaki Chayama and Wan-Long Chuang and Hugo Fainboim and Martti Farkkila and Adrian Gadano and Gaeta, {Giovanni B.} and Christophe Hezode and Yukiko Inada and Jeong Heo and Hiromitsu Kumada and Sheng-Nan Lu and Patrick Marcellin and Christophe Moreno and Roberts, {Stuart K.} and Strasser, {Simone I.} and Thompson, {Alexander J.} and Joji Toyota and Paik, {Seung Woon} and Vierling, {John M.} and Zignego, {Anna L.} and David Cohen and Fiona McPhee and Megan Wind-Rotolo and Subasree Srinivasan and Matthew Hruska and Heather Myler and Portsmouth, {Simon D.}",
year = "2016",
month = "8",
day = "19",
doi = "10.1186/s40064-016-2920-z",
language = "English",
volume = "5",
journal = "SpringerPlus",
issn = "2193-1801",
publisher = "Springer International Publishing AG",

}

Foster, GR, Chayama, K, Chuang, W-L, Fainboim, H, Farkkila, M, Gadano, A, Gaeta, GB, Hezode, C, Inada, Y, Heo, J, Kumada, H, Lu, S-N, Marcellin, P, Moreno, C, Roberts, SK, Strasser, SI, Thompson, AJ, Toyota, J, Paik, SW, Vierling, JM, Zignego, AL, Cohen, D, McPhee, F, Wind-Rotolo, M, Srinivasan, S, Hruska, M, Myler, H & Portsmouth, SD 2016, 'A randomized, controlled study of peginterferon lambda-1a/ribavirin +/- daclatasvir for hepatitis C virus genotype 2 or 3', SpringerPlus, Vuosikerta 5, 1365. https://doi.org/10.1186/s40064-016-2920-z

A randomized, controlled study of peginterferon lambda-1a/ribavirin +/- daclatasvir for hepatitis C virus genotype 2 or 3. / Foster, Graham R.; Chayama, Kazuaki; Chuang, Wan-Long; Fainboim, Hugo; Farkkila, Martti; Gadano, Adrian; Gaeta, Giovanni B.; Hezode, Christophe; Inada, Yukiko; Heo, Jeong; Kumada, Hiromitsu; Lu, Sheng-Nan; Marcellin, Patrick; Moreno, Christophe; Roberts, Stuart K.; Strasser, Simone I.; Thompson, Alexander J.; Toyota, Joji; Paik, Seung Woon; Vierling, John M.; Zignego, Anna L.; Cohen, David; McPhee, Fiona; Wind-Rotolo, Megan; Srinivasan, Subasree; Hruska, Matthew; Myler, Heather; Portsmouth, Simon D.

julkaisussa: SpringerPlus, Vuosikerta 5, 1365, 19.08.2016.

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

TY - JOUR

T1 - A randomized, controlled study of peginterferon lambda-1a/ribavirin +/- daclatasvir for hepatitis C virus genotype 2 or 3

AU - Foster, Graham R.

AU - Chayama, Kazuaki

AU - Chuang, Wan-Long

AU - Fainboim, Hugo

AU - Farkkila, Martti

AU - Gadano, Adrian

AU - Gaeta, Giovanni B.

AU - Hezode, Christophe

AU - Inada, Yukiko

AU - Heo, Jeong

AU - Kumada, Hiromitsu

AU - Lu, Sheng-Nan

AU - Marcellin, Patrick

AU - Moreno, Christophe

AU - Roberts, Stuart K.

AU - Strasser, Simone I.

AU - Thompson, Alexander J.

AU - Toyota, Joji

AU - Paik, Seung Woon

AU - Vierling, John M.

AU - Zignego, Anna L.

AU - Cohen, David

AU - McPhee, Fiona

AU - Wind-Rotolo, Megan

AU - Srinivasan, Subasree

AU - Hruska, Matthew

AU - Myler, Heather

AU - Portsmouth, Simon D.

PY - 2016/8/19

Y1 - 2016/8/19

KW - Hepatitis C virus

KW - Genotype 2

KW - Genotype 3

KW - Peginterferon lambda-1a

KW - Peginterferon alfa-2a

KW - PLUS SOFOSBUVIR

KW - HCV GENOTYPE-2

KW - RIBAVIRIN

KW - THERAPY

KW - INFECTION

KW - CIRRHOSIS

KW - 3121 Internal medicine

U2 - 10.1186/s40064-016-2920-z

DO - 10.1186/s40064-016-2920-z

M3 - Article

VL - 5

JO - SpringerPlus

JF - SpringerPlus

SN - 2193-1801

M1 - 1365

ER -